Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 EBV LMP1: New and shared pathways to NF-κB activation.

Literature DB >> 22308477

EBV LMP1: New and shared pathways to NF-κB activation.

Alfonso Lavorgna¹, Edward W Harhaj.

Abstract

Entities: Gene

Mesh：

Substances：

Year: 2012 PMID： 22308477 PMCID： PMC3289357 DOI： 10.1073/pnas.1121357109

Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN： 0027-8424 Impact factor: 11.205

× No keyword cloud information.

18 in total

Review 1. Shared principles in NF-kappaB signaling.

Authors: Matthew S Hayden; Sankar Ghosh
Journal: Cell Date: 2008-02-08 Impact factor: 41.582

2. The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation.

Authors: K M Izumi; K M Kaye; E D Kieff
Journal: Proc Natl Acad Sci U S A Date: 1997-02-18 Impact factor: 11.205

3. Localization of the major NF-kappaB-activating site and the sole TRAF3 binding site of LMP-1 defines two distinct signaling motifs.

Authors: S R Brodeur; G Cheng; D Baltimore; D A Thorley-Lawson
Journal: J Biol Chem Date: 1997-08-08 Impact factor: 5.157

4. Transformation of foetal human keukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus.

Authors: J H Pope; M K Horne; W Scott
Journal: Int J Cancer Date: 1968-11-15 Impact factor: 7.396

5. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.

Authors: K M Kaye; K M Izumi; E Kieff
Journal: Proc Natl Acad Sci U S A Date: 1993-10-01 Impact factor: 11.205

6. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain.

Authors: D S Huen; S A Henderson; D Croom-Carter; M Rowe
Journal: Oncogene Date: 1995-02-02 Impact factor: 9.867

7. Stimulation of NF-kappa B-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus.

Authors: T Mitchell; B Sugden
Journal: J Virol Date: 1995-05 Impact factor: 5.103

8. The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB.

Authors: K M Izumi; E D Kieff
Journal: Proc Natl Acad Sci U S A Date: 1997-11-11 Impact factor: 11.205

9. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family.

Authors: G Mosialos; M Birkenbach; R Yalamanchili; T VanArsdale; C Ware; E Kieff
Journal: Cell Date: 1995-02-10 Impact factor: 41.582

10. Compensatory IKKalpha activation of classical NF-kappaB signaling during IKKbeta inhibition identified by an RNA interference sensitization screen.

Authors: Lloyd T Lam; R Eric Davis; Vu N Ngo; Georg Lenz; George Wright; Weihong Xu; Hong Zhao; Xin Yu; Lenny Dang; Louis M Staudt
Journal: Proc Natl Acad Sci U S A Date: 2008-12-22 Impact factor: 11.205

13 in total

1. EB-virus latent membrane protein 1 potentiates the stemness of nasopharyngeal carcinoma via preferential activation of PI3K/AKT pathway by a positive feedback loop.

Authors: C-F Yang; G-D Yang; T-J Huang; R Li; Q-Q Chu; L Xu; M-S Wang; M-D Cai; L Zhong; H-J Wei; H-B Huang; J-L Huang; C-N Qian; B-J Huang
Journal: Oncogene Date: 2015-11-16 Impact factor: 9.867

Review 2. Influenza viral manipulation of sphingolipid metabolism and signaling to modulate host defense system.

Authors: Madhuvanthi Vijayan; Bumsuk Hahm
Journal: Scientifica (Cairo) Date: 2014-01-23

3. Human papillomavirus and Epstein-Barr virus co-infection in cervical carcinoma in Algerian women.

Authors: Abdelhalim Khenchouche; Nabila Sadouki; Arab Boudriche; Karim Houali; Abdelaziz Graba; Tadamasa Ooka; Abdelmadjid Bouguermouh
Journal: Virol J Date: 2013-11-19 Impact factor: 4.099

4. Niacin Suppresses Progression of Atherosclerosis by Inhibiting Vascular Inflammation and Apoptosis of Vascular Smooth Muscle Cells.

Authors: Gang Su; Guangli Sun; Hai Liu; Liliang Shu; Jingchao Zhang; Longhui Guo; Chen Huang; Jing Xu
Journal: Med Sci Monit Date: 2015-12-29

9. Capn4 is a marker of poor clinical outcomes and promotes nasopharyngeal carcinoma metastasis via nuclear factor-κB-induced matrix metalloproteinase 2 expression.

Authors: Pei-Chan Zheng; Xiong Chen; Hong-Wu Zhu; Wei Zheng; Li-Hua Mao; Cheng Lin; Jing-Nan Liu; Ming Zheng
Journal: Cancer Sci Date: 2014-05-21 Impact factor: 6.716

Review 10. Cancer-Associated Fibroblasts in Undifferentiated Nasopharyngeal Carcinoma: A Putative Role for the EBV-Encoded Oncoprotein, LMP1.

Authors: Mhairi A Morris
Journal: Pathogens Date: 2019-12-20